Patent · US Active

Methods for treating, diagnosing, and monitoring lupus

US10053734B2 · kind B2 · utility

1Cited by
15References
22Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 10, 2016
Grant dateAug 21, 2018
Priority date
Expiry dateFeb 10, 2036

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12Q2600/156
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Methods of identifying, diagnosing, and prognosing lupus, including certain subphenotypes of lupus, are provided, as well as methods of treating lupus, including certain subpopulations of patients. The methods provided are based on a set of alleles associated with systemic lupus erythematosus (SLE) risk loci including BLK, TNIP1, PRDM1, JAZF1, UHRF1BP1, IL10, IFIH1, CFB, CEC16A, IL12B and SH2B3 that contribute to SLE risk. Also provided are methods for identifying effective lupus therapeutic agents and predicting responsiveness to lupus therapeutic agents.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.